Your session is about to expire
← Back to Search
Behavioral Intervention
Low-Carbohydrate Diet for Amputation (PARADE Trial)
N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Amputation at least 6 months prior Phase 1
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (week 0), immediately after the intervention (week 6)
Awards & highlights
Summary
This trial will help to assess the feasibility and efficacy of a low-carbohydrate diet to reduce pain and improve quality of life in amputees.
Eligible Conditions
- Amputation
- Phantom Limb Pain
- Residual Limb Pain
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (week 0), immediately after the intervention (week 6)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (week 0), immediately after the intervention (week 6)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
BPI Pain Interference Change
BPI Pain Severity Change
SF-36 overall score change
Secondary outcome measures
AAQ change score
CES-D score change
CFS score change
+6 moreOther outcome measures
Weight change
Trial Design
1Treatment groups
Experimental Treatment
Group I: Phase 2 InterventionExperimental Treatment1 Intervention
Low-Carbohydrate Diet
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low-Carbohydrate Diet
2022
N/A
~990
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,599 Previous Clinical Trials
2,287,892 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You had a limb amputated within the past 6 months.
Research Study Groups:
This trial has the following groups:- Group 1: Phase 2 Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger